The combination of tumor mutational burden and T-cell receptor repertoire predicts the response to immunotherapy in patients with advanced non-small cell lung cancerMEDCOMMIF10.72024-06-051OAAI
Changes in hospitalizations for respiratory diseases following the COVID-19 epidemicCHINESE MEDICAL JOURNALIF7.32022-10-052OAAI
Management of pulmonary nodules in non-high-risk population: initial evidence from a real-world prospective cohort study in ChinaCHINESE MEDICAL JOURNALIF7.32022-04-205OAAI
未登录.png){kind=icon}
未登录
